Does in-house availability of multidisciplinary teams increase survival in upper gastrointestinal-cancer?

doi:10.4251/wjgo.v5.i3.60

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5206)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

402

HTML

3095

Figures (1-1)

131

Tables (1-2)

157

Sum=3785

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

674

Download

747

Sum=1421

Mar 15, 2013 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Oncol. Mar 15, 2013; 5(3): 60-67
Published online Mar 15, 2013. doi: 10.4251/wjgo.v5.i3.60

Table 2 Patient characteristics n(%)

	Diagnosed Jan 2000-Dec 2004					Diagnosed Jan 2005-Dec 2008
	MDT-Mix	MDT-No	MDT-Change	MDT-Yes	Other regions	MDT-Mix	MDT-No	MDT-Change	MDT-Yes	Other regions
Tumor type
Oesophagus	113 (15.4)	31 (11.8)	30 (14.6)	68 (10.0)	657 (12.9)	91 (15.2)	35 (16.2)	30 (19.6)	72 (12.8)	571 (14.1)
Gastric	258 (35.2)	110 (41.8)	77 (37.6)	318 (47.0)	2146 (42.2)	214 (35.8)	73 (33.8)	45 (29.4)	240 (42.6)	1534 (38.0)
Pancreas	362 (49.4)	122 (46.4)	98 (47.8)	291 (43.0)	2278 (44.8)	293 (49.0)	108 (50.0)	78 (51.0)	252 (44.7)	1935 (47.9)
Total	733 (100.0)	263 (100.0)	205 (100.0)	677 (100.0)	5081 (100.0)	598 (100.0)	216 (100.0)	153 (100.0)	564 (100.0)	4040 (100.0)
Stage
No metastasis	109 (14.9)	38 (14.4)	28 (13.7)	81 (12.0)	694 (13.7)	59 (9.9)	30 (13.9)	28 (18.3)	71 (12.6)	543 (13.4)
Lymph node metastasis	155 (21.1)	62 (23.6)	49 (23.9)	182 (26.9)	1195 (23.5)	125 (20.9)	52 (24.1)	44 (28.8)	141 (25.0)	926 (22.9)
Distant metastasis	293 (40.0)	104 (39.5)	85 (41.5)	303 (44.8)	2083 (41.0)	237 (39.6)	97 (44.9)	57 (37.3)	237 (42.0)	1642 (40.6)
Unknown	176 (24.0)	59 (22.4)	43 (21.0)	111 (16.4)	1109 (21.8)	177 (29.6)	37 (17.1)	24 (15.7)	115 (20.4)	929 (23.0)
Total	733 (100.0)	263 (100.0)	205 (100.0)	677 (100.0)	5081 (100.0)	598 (100.0)	216 (100.0)	153 (100.0)	564 (100.0)	4040 (100.0)

MDT: Multidisciplinary team. No clinically relevant differences in stage distribution were revealed among the analyzed regions or between the two calendar periods. In addition, there were no clinically relevant differences in stage distribution among the studied counties.

Citation: Kersten C, Cvancarova M, Mjåland S, Mjåland O. Does in-house availability of multidisciplinary teams increase survival in upper gastrointestinal-cancer? World J Gastrointest Oncol 2013; 5(3): 60-67
URL: https://www.wjgnet.com/1948-5204/full/v5/i3/60.htm
DOI: https://dx.doi.org/10.4251/wjgo.v5.i3.60